-
RHS National meeting on 13 November
The yearly national meeting for the Swedish HD patients’ organization, RHS, will be held in Uppsala on 13 November 2026. On the agenda is a talk on HD research and clinical trials by Åsa Petersén. Se RHS website for more information (opens in a new window)
-
Applications granted!
This is the time of the year when researcher are kept in suspense, awaiting decisions on submitted applications. And now the decisions are published! Åsa Petersén has been granted continued support from both the ALF system and the Swedish Research Council for the coming three years. She has also received funding from the Swedish Brain…
-
TNU researchers at EHDN Congress in Kraków
The European Huntington’s Disease Network, EHDN, held a clinical research congress in Kraków on 22-24 October 2026. This was the largest congress ever for EHDN with over 1300 participants. The programme included an overview of the development of clinical therapies, the family and patient perspective of HD, lectures on genetic testing, update on ongoing research…
-
Petersén gives a talk at the Huntington Disease Foundation’s conference in Boston, August, 2026
The HD2026 Milton Wexler Biennial Symposium took place in Boston in August 2026, organized by the Huntington Disease Foundation. Around 300 invited participants discussed science over four days. The talks are summarised at HD Buzz: Link to HD Buzz’ webpage (opens in a new window) Dr. Hoa Nguyen, Ruhr University Bochum, Dr. X. William Yang,…
-
Dr. Petersén in webinar with European Huntington Association and Novartis on Invest-HD trial
From European Huntington Association: Join us for an open webinar with Novartis to get the latest updates on the INVEST-HD trial, including timeline updates and insights from a clinical perspective. Featuring presentations by Beth Borowsky, Senior Global Programme Clinical Head in Neuroscience at Novartis, and Åsa Petersén, MD PhD from Lund University, followed by a…
-
Sofia Berg thesis defence 6 May 2026
Sofia Bergh, PhD student in Åsa Petersén’s research group at Lund University, will defend her dissertation in May. One part of the studies during the past four years has been to test the hypothesis that hypothalamus is vulnerable to mutant huntingtin and to the protein TDP-43. Time: Wednesday 6 May at 13.00Venue: Belfrage lecture hall,…
-
Huntington centre’s MDs take part in Swedish conference
For the first time ever, the four Swedish patients’ organizations for Alzheimer’s, Huntington, Parkinson’s and ALS are arranging a joint conference on neurodegenerative diseases. Åsa Petersén, Professor and Senior Consultant in Psychiatry, and Håkan Widner, Professor and Senior Consultant in Neurology, both active at the Huntington Disease Centre in Lund, will be taking part in…
-
Pod on Huntington’s disease with Åsa Petersén
Åsa Petersén has been interviewed by the website “Vetenskap & Hälsa” (Science & Health) about Huntington’s disease and the ongoing research to find a future treatment. Recent research has come up with some interesting findings, which are crucial for the development of efficient treatments Link to the pod on the Vetenskap & Hälsa website –…
-
Petersén’s talk at RHS meeting 2025
The Swedish patients’ organisation, RHS, held their yearly meeting in October 2025 and Professor Åsa Petersén was invited speaker. Petersén’s talk addressed early symptoms in HD connected to research. The meeting was recorded and the films are now available on RHS’ website. Link to the content at RHS’ website – in Swedish only (opens in…
-
Petersén gives talk at Scottish Huntington’s Association Meeting
Petersén is invited to give a talk at the 2025 Family Gathering for the Scottish Huntington’s Association with around 170 attendees on November 8, 2025 in Glasgow. Link to the programme at the association’s webpage (opens in a new window)